Bonus Issues, Stock Splits, Rights Issues, IPO Updates: Dalal Street Choice Scrip Buy Calls - Biocon |
Dalal Street Choice Scrip Buy Calls - Biocon Posted: 05 Mar 2010 05:58 PM PST Biocon CMP: Rs. 262 Investment: 1 Year Target: Rs. 343 With 30 million diabetic patients in India, Biocon is well-placed to deliver good growth ahead with its insulin portfolio. In diabetology the company is growing at a rapid rate of 40 per cent in the domestic segment. The company enjoys a market share of 12 per cent in the [...] Read More... |
Record Date - Hindustan Dorr-Oliver Bonus Issue Posted: 05 Mar 2010 05:45 PM PST |
You are subscribed to email updates from Stock Market India Bonus Issues, Stock Splits, Right Issues and Market News To stop receiving these emails, you may unsubscribe now. | Email delivery powered by Google |
Google Inc., 20 West Kinzie, Chicago IL USA 60610 |
No comments:
Post a Comment